← Back to headlines
New Weight-Loss Pill Shows Promise for Type 2 Diabetes Patients
Results from the most comprehensive study to date on the active ingredient orforglipron, published in The Lancet, indicate that a new weight-loss tablet could significantly help patients with type 2 diabetes.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
